Evaluation of primary aldosteronism

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 17, Issue 3, 2010, Pages 188-193

  Mulatero, Paolo ^a   Monticone, Silvia ^a   Bertello, Chiara ^a   Tizzani, Davide ^a   Iannaccone, Andrea ^a   Crudo, Valentina ^a   Veglio, Franco ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Adrenal vein sampling; Aldosterone; Primary aldosteronism; Saline load

Indexed keywords

ALISKIREN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DEXAMETHASONE; EPLERENONE; MINERALOCORTICOID ANTAGONIST; SPIRONOLACTONE; VERAPAMIL;

ADRENALECTOMY; CARDIOVASCULAR DISEASE; CLINICAL EVALUATION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; MULTIPLE ORGAN FAILURE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY HYPERALDOSTERONISM; REVIEW; SCREENING;

ADRENALECTOMY; CARDIOVASCULAR DISEASES; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MASS SCREENING; RECEPTORS, MINERALOCORTICOID; RISK FACTORS;

EID: 77951855874     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283390f8d     Document Type: Review

References (68)

1. Conn JW. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955; 45:6-17.
2. Ganguly A. Primary aldosteronism. N Engl J Med 1998; 339:1828-1834. (Pubitemid 29005789)
3. Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89:1045-1050. (Pubitemid 38368386)
4. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: an endocrine society clinical practice guidelines. J Clin Endocrinol Metab 2008; 93:3266-3281.
5. Mosso L, Carvajal C, Gonzá lez A, et al. Primary aldosteronism and hypertensive disease. Hypertension 2003; 42:161-165. (Pubitemid 36944590)
6. Calhoun DA, Nishizaka MK, Zaman MA, et al. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002; 40:892-896. (Pubitemid 35434912)
7. Mulatero P, Milan A, Rabbia F, et al. Diagnosis of surgically treatable forms of primary aldosteronism. Curr Hypert Rev 2005; 1:259-266.
8. Todesco S, Terribile V, Borsatti A, Mantero F. Primary aldosteronism due to a malignant ovrian tumor. J Clin Endocrinol Metab 1975; 41:809-819.
9. Mulatero P, Rabbia F, Veglio F. Paraneoplastic hyperaldosteronism associated with non-Hodgkin's lymphoma. N Engl J Med 2001; 344:1558-1559. (Pubitemid 32429223)
10. Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45:1243-1248. (Pubitemid 40523144)
11. Mulatero P, Milan A, Williams TA, Veglio F. Mineralocorticoid receptor blockade in the protection of target organ damage. Cardiovasc Hematol Agents Med Chem 2006; 4:75-91. (Pubitemid 43796702)
12. Montori VM, Young JrWF. Use of plasma aldosterone concentration-toplasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am 2002; 31:619-632. (Pubitemid 35006613)
13. Rossi GP, Seccia TM, Palumbo G, et al. Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Hypertension 2010; 55:83-89.
14. Olivieri O, Ciacciarelli A, Signorelli D, et al. Aldosterone to renin ratio in a primary care setting: the Bussolengo Study. J Clin Endocrinol Metab 2004; 89:4221-4226. (Pubitemid 39244414)
15. Hartman D, Sagnella GA, Chester CA, MacGragor GA. Direct renin assay and plasma rennin activity assay compared. Clin Chem 2004; 50:2159-2161. (Pubitemid 39425859)
16. Loh KC, Koay ES, Khaw MC, et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85:2854-2859.
17. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol 2007; 66:607-618.
18. Stowasser M, Gordon RD. Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 2003; 17:591-605. (Pubitemid 37493008)
19. Stowasser M, Gordon RD, Rutheford JC, et al. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2001; 2:156-169. (Pubitemid 33685887)
20. Mulatero P, Rabbia F, Milan A, et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002; 40:897-902. (Pubitemid 35434913)
21. Young WF Jr. Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 2003; 144:2208-2213. (Pubitemid 36629868)
22. Seiler L, Rump LC, Schulte-Mönting J, et al. Diagnosis of primary aldosteronism: value of different screening parameters and inuence of antihypertensive medication. Eur J Endocrinol 2004; 150:329-337. (Pubitemid 38443783)
23. Whitworth JA, Butty J, Gordon D. Acute haemodynamic and hormonal effects of oral doxazosin in normal subjects. Clin Exp Pharmacol Physiol 1987; 14:133-135. (Pubitemid 17074586)
24. Mulatero P, Bertello C, Rossato D, et al. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab 2008; 93:1366-1371. (Pubitemid 351519734)
25. Celen O, O'Brien MJ, Melby JC, Beazley RM. Factors influencing out-come of surgery for primary aldosteronism. Arch Surg 1996; 131:646-650. (Pubitemid 26175585)
26. Streeten DH, Anderson GH Jr, Wagner S. Effect of age on response of secondary hypertension to specific treatment. Am J Hypertens 1990; 3:360-365. (Pubitemid 20188287)
27. Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008; 168:80-85.
28. Sealey JE, Gordon RD, Mantero F. Plasma renin and aldosterone measurements in low renin hypertensive states. Trends Endocrinol Metab 2005; 16:86-91. (Pubitemid 40432456)
29. Mulatero P, Verhovez A, Morello F, Veglio F. Diagnosis and treatment of lowrenin hypertension. Clin Endocrinol (Oxf) 2007; 67:324-334.
30. Mulatero P, Monticone S, Bertello C, et al. Confirmatory tests in the diagnosis of primary aldosteronism. Horm Metab Res 2010. [Epub ahead of print]
31. Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006; 48:2293-2300. (Pubitemid 44873058)
32. Lyons DF, Kem DC, Brown RD, et al. Single dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocrinol Metab 1983; 57:892-896.
33. Agharazii M, Douville P, Grose JH, Lebel M. Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 2001; 37:1440-1443. (Pubitemid 34225389)
34. Castro OL, Yu X, Kem DC. Diagnostic value of the postcaptopril test in primary aldosteronism. Hypertension 2002; 39:935-938. (Pubitemid 34437553)
35. Omura M, Saito J, Yamaguchi K, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004; 27:193-202. (Pubitemid 38489081)
36. Giacchetti G, Ronconi V, Lucarelli G, et al. Analysis of screening and conrmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens 2006; 24:737-745.
37. Wu VC, Chang HW, Liu KL, et al. Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests. Am J Hypertens 2009; 22:821-827.
38. Stowasser M. Update in primary aldosteronism. J Clin Endocrinol Metab 2009; 94:3623-3630.
39. Mulatero P, Milan A, Fallo F, et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism: diagnosis of PA. J Clin Endocrinol Metab 2006; 91:2618-2623. (Pubitemid 44024627)
40. Rossi GP, Belfiore A, Bernini G, et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 2007; 50:424-431. (Pubitemid 47205795)
41. Mulatero P, Bertello C, Garrone C, et al. Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension 2007; 50:e26-e27. (Pubitemid 47205812)
42. Mulatero P, Bertello C, Verhovez A, et al. Differential diagnosis of primary aldosteronism subtypes. Curr Hypertens Rep 2009; 11:217-223.
43. Young WF, Stanson AW, Thompson GB, et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004; 136:1227-1235.
44. Nwariaku FE, Miller BS, Auchus R, et al. Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg 2006; 141:497-502. (Pubitemid 43727575)
45. Young WF. Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism. Rev Endocr Metab Disord 2007; 8:309-320.
46. Mansoor GA, Malchoff CD, Arici MH, et al. Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning. Am J Hypertens 2002; 15:459-464.
47. Vetter H, Fischer M, Galanski M, et al. Primary aldosteronism: diagnosis and noninvasive lateralization procedures. Cardiology 1985; 72 (Suppl. 1):57-63. (Pubitemid 16146016)
48. Gross MD. Limited signicance of asymmetric adrenal visualisation on dexamethasone suppression scintigraphy. J Nucl Med 1985; 26:43-48.
49. Young WF, Stanson AW. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol (Oxf) 2009; 70:14-17.
50. Doppman JL, Gill JR Jr. Hyperaldosteronism: sampling the adrenal veins. Radiology 1996; 198:309-312.
51. Miotto D, De Toni R, Pitter G, et al. Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism. Hypertension 2009; 54:885-889.
52. Rossi GP, Sacchetto A, Chiesura-Corona M, et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001; 86:1083-1090. (Pubitemid 32322986)
53. Stowasser M, Gordon RD, Gunasekera TG, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after "nonselective" screening of hypertensive patients. J Hypertens 2003; 21:2149-2157. (Pubitemid 38296877)
54. Young WF Jr, Klee GG. Primary aldosteronism. Diagnostic evaluation. Endocrinol Metab Clin North Am 1988; 17:367-395.
55. Mengozzi G, Rossato D, Bertello C, et al. Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin Chem 2007; 53:1968-1971. (Pubitemid 350036044)
56. Mulatero P, Bertello C, Sukor N, et al. Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension 2010; 55:667-673.
57. Seccia TM, Miotto D, De Toni R, Pitter G, et al. Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension 2009; 53:761-766.
58. Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11b-hydroxylase/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355:262-265.
59. Mulatero P, Morello F, Veglio F. Genetics of primary aldosteronism. J Hypertens 2004; 22:663-670. (Pubitemid 38543550)
60. Sukor N, Mulatero P, Gordon RD, et al. Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J Hypertens 2008; 26:1577-1582.
61. Lafferty AR, Torpy DJ, Stowasser M, et al. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 2000; 37:831-835.
62. Newton-Cheh C, Guo CY, Gona P, et al. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 2007; 49:846-856. (Pubitemid 351664212)
63. Geller DS, Zhang JJ, Wisgerhof MV, et al. A novel form of humanMendelian hypertension featuring nonglucocorticoid remediable aldosteronism. J Clin Endocrinol Metab 2008; 93:3117-3123.
64. Mulatero P. A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J Clin Endocrinol Metab 2008; 93:2972-2974.
65. Sawka AM, Young WF, Thompson GB, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 2001; 135:258-261. (Pubitemid 32799339)
66. Sukor N, Kogovsek C, Gordon RD, et al. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J Clin Endocrinol Metab 2010; 95:1360-1364.
67. Sukor N, Gordon RD, Ku YK, et al. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab 2009; 94:2437-2445.
68. Karagiannis A, Tziomalos K, Papageorgiou A, et al. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opin Pharmacother 2008; 9:509-515. (Pubitemid 351425379)